drugset / Trial / NCT05584956
Clinical Study to Evaluate the Possible Efficacy and Safety of L- Carnitine and Sildenafil in Children Having Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to investigate the possible efficacy and safety of L\_Carnitine and Sildenafil on patient with Beta thalassemia complicated with increased Tricuspid Regurgitant Jet Velocity
Timeline
- Start
- 2022-07-08
- Primary completion
- 2023-07-08
- Completion
- 2024-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | L-carnitine | Other / unclassified | 50 mg/kg | Oral |
| Comparator | Sildenafil | Unknown | 0.25 mg/kg | Oral |